The litigation, spearheaded by the Rosen Law Firm, centers on claims that Microvast executives issued materially false statements during the specified period. According to the complaint, the company failed to disclose significant inventory management struggles and delays involving its commercial vehicle customers. These undisclosed operational hurdles allegedly compromised the firm's ability to meet projected margin goals and stalled the completion of the Huzhou Phase 3.2 manufacturing expansion, which was initially slated for the end of 2025.

Shareholders who incurred losses following these disclosures are eligible to participate in the litigation. While a class has not yet been certified, affected investors may retain their own counsel or choose to remain absent members of the class. Serving as a lead plaintiff requires a formal motion to the court by the September deadline, though participation in any eventual recovery does not strictly mandate this leadership role. The Rosen Law Firm maintains that investors should vet legal representation carefully, citing their own history of high-stakes settlements in shareholder derivative litigation.